Harlos, C., Musto, G., Lambert, P., Ahmed, R
Injection Site Reactions More common with IGF-1 DES , which is injected directly into the muscle: Localized redness or swelling Muscle soreness Temporary inflammation These reactions usually resolve within a day
Clinical trials, including Phase 2 studies, have evaluated the efficacy and safety of Retatrutide in adults with obesity and type 2 diabetes, showing substantial reductions in body weight and improvements in metabolic markers
By the numbers: the rise in GLP-1 costs Since the Food and Drug Administration (FDA) approved Wegovy a manufactured version of GLP-1 that targets several areas of the brain to regulate appetite and food intake net sales of all anti-obesity medications in the U.S